AB3A Intrinsic Valuation and Fundamental Analysis - Sarepta Therapeutics Inc

S	Sarepta Therapeutics Inc XBER:AB3A	US
	Foresight Group Holdings Ltd F:9LR	UK
	PayPal Holdings Inc BMV:PYPL	US
T	TJX Companies Inc XMUN:TJX	US
B	Barrick Gold Corp F:ABR	CA
P	Parker-Hannifin Corp XMUN:PAR	US
	PTC Therapeutics Inc F:BH3	US

Intrinsic Value

The intrinsic value for Sarepta Therapeutics Inc (AB3A) under the Base Case is hidden EUR. Compared with the current market price of 18.185 EUR, the stock appears hidden .

Intrinsic value calculated using Multiples

Locked

Other reference points

DCF valuation

Locked

Wall St target

€30.814

Do our valuations actually work? See backtest results .

AB3A Intrinsic Value

Unlock

Track Buy Zone

20% below Intrinsic Value

Get notified when the price drops into your buy zone

Intrinsic Value Locked

Margin of Safety 20% Locked

Current Price €18.19

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

AB3A looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if AB3A is one of them.

See where today’s valuation sits in AB3A’s own history and what typically happened over the next 12 months after similar periods.

Show Historical Valuation

What is Valuation History?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for Sarepta Therapeutics Inc.

Explain Valuation